0K05.L

Medifast, Inc.
LSEUSDEQUITY DELAYED
Last price
12.09
▲ 0.18 (1.51%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
11.98
Prev close
11.91
Day high
12.26
Day low
11.80
Volume
246
Market cap
P/E (TTM)
0.01
52W range
11.80 – 109.46

Day trading desk

Current session · delayed
Gap from prior close
VWAP
12.13
-0.30% from price
Relative volume
0.54×
Quiet session
Session range
3.90%
11.80 – 12.26
Position in range
63%
Mid range
ATR (14D)
Daily true range
Prior day high
PDH
Prior day low
PDL
Bid / ask spread
Quote not published
Session volume
245
Avg 450

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 0K05.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
430.81K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 20, 26
KIAI PARSA
Director
BUY 72.49K $842.70K Indirect
May 26, 26
GEARY ELIZABETH A.
Director
STOCK 11.68K $0 Direct
May 26, 26
KIAI PARSA
Director
STOCK 19.32K $0 Direct
May 26, 26
ROSE JEFFREY MATTHEW
Director
STOCK 18.42K $0 Direct
May 26, 26
SCHLACKMAN SCOTT
Director
STOCK 11.68K $0 Direct
May 26, 26
THOMAS ANDREA B
Director
STOCK 11.68K $0 Direct
May 11, 26
SCHLACKMAN SCOTT
Director
BUY 5.00K $62.95K Direct
Mar 25, 26
CHARD DANIEL R
Chief Executive Officer
STOCK 41.80K $0 Direct
Mar 25, 26
MALONEY JAMES P.
Chief Financial Officer
STOCK 35.36K $0 Direct
Mar 25, 26
MACKENZIE JONATHAN BARRETT
Officer
STOCK 10.83K $0 Direct
Mar 20, 26
CHARD DANIEL R
Chief Executive Officer
BUY 17.68K $178.72K Indirect
Jun 25, 25
GEARY ELIZABETH A.
Director
STOCK 11.17K $0 Direct
Jun 25, 25
BROWN JEFFREY J.
Director
STOCK 20.62K $126.53K Direct
Jun 25, 25
SCHLACKMAN SCOTT
Director
STOCK 11.17K $0 Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BROWN JEFFREY J.
Director 42.81K Stock Award(Grant)
CHARD DANIEL R
Chief Executive Officer 355.61K Stock Award(Grant)
GEARY ELIZABETH A.
Director 31.23K Stock Award(Grant)
HOER MICHAEL A.
Director 26.14K Stock Award(Grant)
KIAI PARSA
Director Purchase
MACKENZIE JONATHAN BARRETT
Officer 20.84K Stock Award(Grant)
MALONEY JAMES P.
Chief Financial Officer 73.03K Stock Award(Grant)
ROSE JEFFREY MATTHEW
Director 18.42K Stock Award(Grant)
SCHLACKMAN SCOTT
Director 42.23K Stock Award(Grant)
THOMAS ANDREA B
Director 35.70K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap
Enterprise value$-17.21M
Revenue (TTM)$316.93M
Gross profit$219.45M
EBITDA$-5.66M
Net income$-25.60M
EPS (TTM)$14.02
Free cash flow$11.37M
Total cash$169.82M
Total debt$27.62M
Book value / share$18.99
Shares outstanding11.96M
Float8.38M
Short % of float
Dividend yield
Beta (5Y)0.70

Valuation & profitability ratios

Account required
Trailing P/E0.01
Forward P/E
PEG ratio
Price / sales
Price / book0.63
EV / revenue-0.05
EV / EBITDA3.04
Gross margin69.24%
Operating margin-5.66%
Profit margin-8.08%
Return on equity-12.42%
Return on assets-4.60%
Debt / equity14.06
Current ratio4.86
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $71.30M -20.3%
Next quarter $64.10M -14.6%
Current year $287.70M
Next year $273.70M -4.9%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders4.17%
Held by institutions75.69%
Institutions holding151
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Options chain

Account required
Expiry
Spot 12.09
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
0.70
5Y monthly, from filing

Rating changes

53 on file
DateFirm ActionFromTo
Feb 19, 26 Stephens & Co. MAINTAINED Equal-Weight Equal-Weight
Feb 19, 25 DA Davidson MAINTAINED Neutral Neutral
Nov 5, 24 DA Davidson UPGRADE Underperform Neutral
Jul 22, 24 DA Davidson MAINTAINED Underperform Underperform
Jun 5, 24 DA Davidson DOWNGRADE Neutral Underperform
Apr 30, 24 DA Davidson MAINTAINED Neutral Neutral
Feb 21, 24 DA Davidson MAINTAINED Neutral Neutral
Oct 13, 23 Stephens & Co. INITIATED Equal-Weight
Aug 8, 23 DA Davidson MAINTAINED Neutral Neutral
Jul 31, 23 DA Davidson MAINTAINED Neutral Neutral
May 2, 23 DA Davidson MAINTAINED Neutral
Feb 22, 23 DA Davidson MAINTAINED Neutral

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.